Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Jazz Pharmaceuticals PLC (JAZZ) had Free Cash Flow per Share of $7.66 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.20B |
|
$203.45M |
|
$153.53M |
|
$1.04B |
|
$943.39M |
|
$254.53M |
|
$-46.06M |
|
$208.47M |
|
$208.47M |
|
$203.51M |
|
$203.45M |
|
$203.45M |
|
$203.51M |
|
$254.53M |
|
$433.70M |
|
60.98M |
|
60.98M |
|
$3.28 |
|
$3.34 |
|
| Balance Sheet Financials | |
$4.17B |
|
$199.86M |
|
$7.49B |
|
$11.66B |
|
$2.24B |
|
$4.33B |
|
$5.10B |
|
$7.34B |
|
$4.32B |
|
$-1.94B |
|
$4.32B |
|
61.44M |
|
| Cash Flow Statement Financials | |
$1.36B |
|
$-1.51B |
|
$-873.38M |
|
$2.41B |
|
$1.39B |
|
$-1.02B |
|
$291.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.86 |
|
-- |
|
-- |
|
0.50 |
|
1.24 |
|
87.18% |
|
21.25% |
|
21.25% |
|
-- |
|
17.40% |
|
16.98% |
|
$467.13M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.37 |
|
1.44 |
|
62.41 |
|
4.71% |
|
-10.49% |
|
1.75% |
|
2.35% |
|
$70.30 |
|
|
Free Cash Flow per Share |
$7.66 |
$22.23 |
|